In wake of the legalization of recreational cannabis use in Canada and medicinal cannabis legalization in the UK, the renowned psychiatric research institution leads the way by addressing its own stance on cannabis use.
Following some high-profile cases where children required the use of medicinal cannabis for drug-resistant conditions, Britain has conducted a full-scale review of cannabis classification. Here we look at the significance of this decision and the potential future implications.
With the historical focus being on analysis of CBD and HTC in cannabis, we now find lesser-studied terpenes being recognized as having a potentially highly significant role in the medicinal properties of cannabis. Here we explore these compounds in more detail.
Relaxing the laws on cannabis for medicinal and recreational users would create substantial revenue boost and could see the generation of up to 1 million jobs by 2025.
Dana Rohrabacher publicly confirms his belief that President Trump will allow the legalization of medicinal cannabis use, leaving decisions on recreational use to the discretion of individual states.
In an unprecedented move, U.S. officials have given allowances for cannabis research products to cross the border from Canada to the U.S. Could this herald a change in cannabis regulation for medicinal research?
Data suggests that using alcohol and cannabis in conjunction can affect the likelihood of developing liver damage, compared to alcohol alone.
With speculation mounting over the possibility that Coca-Cola will release a CBD-infused beverage, we take a look at this growing trend for drinks fortified with cannabinoids.